PTO Affirms Shire’s Lialda Patent; First Decision In Kyle Bass IPR Case

Patent board has instituted 19 other inter partes review proceedings sought by the hedge fund manager and declined to institute 14.

Gavel_1200x675

Shire PLC’s success in defeating hedge fund manager Kyle Bass’ attempt to invalidate its Lialda (mesalamine) patent may bode well for other companies facing inter partes review challenges to their patents.

The Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) issued a final written decision on Oct....

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet